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Antimicrobial resistance in the treatment of urinary tract infections is a major health problem. This 
study evaluates the pattern of susceptibility of pathogens commonly responsible for urinary tract 
infections (UTIs) to commonly used antimicrobial agents in Benin City. Midstream urine samples of 700 
patients (300 males and 400 females), who were attending clinics in a 550-bed University of Benin 
Teaching Hospital, Benin City, between April 2003 to March 2004 were examined. Susceptibility of the 
urine bacteria isolates to twelve commonly used antibiotics was investigated. Eight bacteria isolates 
were recovered from 49.5% of the patients (18.1% of males and 31.4% of females). These were 
Escherichia coli (19.7%), Klebsiella aerogenes (15.1%), Proteus mirabilis (6.7%), Acinetobacter 
calcoaceticus (2.3%), Pseudomonas aeruginosa (2.3%), Streptococcus faecalis (1.3%), Providence 
stuartii (1%), and Alkaligenes faecalis (1%). All the isolates exhibited a significantly high resistance to 
tetracycline, co-trimoxazole, amoxycillin and cefuroxime but were either moderately or highly sensitive 
to the quinolones and nitrofurantoin. We conclude that majority of the antimicrobial agents that are 
commonly used to treat UTIs in the hospitals are no longer effective. Therefore, the development and 
strict management of antimicrobial policy, and surveillance for resistant organisms should be given 
priority in Nigeria.  
 





Urinary tract infections (UTIs) are common type of 
bacterial infection accounting for reasonably high health 
care expenditures in people of all ages, with more than 
35 million medically treated infections each year 
(Mindbranch Inc, 2004). This translates into sales in 
excess of $1.1billion across key markets in 2003, with the 
majority of value derived from community management 
(Mindbranch Inc, 2004). Young women, the elderly and 
those undergoing genitourinary instrumentation or cathe-
terization, among others, are also at risk (Kunin, 1994). 
UTIs are the leading cause of gram-negative bacteremia. 
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million office visits and more than 1 million 
hospitalizations, for an overall annual cost in excess of $1 
billion, in the United States (Patton et al., 1991). 
UTIs are usually treated with antibiotics including 
nalidixic acid, nitrofurantoin, ofloxacin, perfloxacin, 
ciprofloxacin, gentamycin, etc. In the last couple of years, 
there has been a lot of focus in scientific literature on 
inappropriate use of antimicrobial agents and the spread 
of bacterial resistance (Gold and Moellering, 1996; 
Tenover and Hughes, 1996; Tenover and McGowan, 
1996). The widespread and inappropriate use of 
antibiotics is recognized as a significant contributing 
factor to the spread of bacterial resistance and the 
development   of   resistance   to    antimicrobial    agents 
(Mincey and Parkulo, 2001). For most bacteria, there is 
evidence that increased usage of a particular 
antimicrobial correlates with increased levels of bacterial




resistance to that agent. For example, the consumption of 
macrolides correlates with the rates of macrolide-
resistance pneumococci (Granizo et al., 2000). There are 
numerous reports in the literature on the incidence of 
growing resistance of urinary isolates to available 
antibiotics (Amyes, 1987; Chesborough, 1985; Gupto et 
al., 1999; Jacoby and Archer, 1991). The emergence of 
antimicrobial resistance in the management of urinary 
tract infections is an important public health issue. While 
many antibiotics including penicillin, macrolides and 
tetracyclines were very useful in the treatment of urinary 
tract infections in the past, the rates of bacterial 
resistance to antimicrobial agents has significantly 
increased and are increasing in many countries in recent 
times (Ho et al., 2004). Despite the well-publicized 
concerns about the problems of inappropriate use of 
antimicrobial agents, or use of broad spectrum antibiotics 
(when narrow spectrum drugs would be effective), 
increasing resistance of bacteria causing urinary tract 
infections to antimicrobial agents remains a serious 
problem (McCaig and Hughes, 1995). With the high 
prevalence of fake and substandard drugs available in 
Nigeria (Raufu, 2002), the rate of bacterial resistance to 
antimicrobial agents in the management of UTIs is likely 
to be much higher than many other countries. 
This study therefore seeks not only to highlight the 
types of urinary tract pathogens treated in a tertiary 
health care facility (University of Benin Teaching 
Hospital) in Benin City, Nigeria, but the degree of 
susceptibility of the pathogens to the commonly used 
antibiotics in the area. The result of this study is expected 
to provide useful information which would assist 
physicians in their good prescribing habits towards a 
better management of urinary tract infections. 
 
 
MATERIALS AND METHODS 
 
Collection of specimen 
 
Midstream urine samples were collected from 700 patients (300 
males and 400 females) attending the clinics (family practice clinic, 
consultant out-patient clinic, obstetrics and gynaecology clinic, and 
accident and emergency clinic) in a 550-bed University of Benin 
Teaching Hospital, Benin City with an out patient attendance of 
over 100,000 patients per annum. These patients did not include 
those who were on any antibiotic a week before the samples were 
collected. The urine samples were collected into labelled 20 ml 
calibrated sterile universal containers distribution to the patients 
suspected by the attending physicians to have UTIs. In each 
container, boric acid (0.2 mg) was added to arrest multiplication of 
bacteria in urine. All patients were instructed on how to collect the 






Each well-mixed urine sample (4.0 µl) was inoculated (in 
duplicates) into the appropriate culture media used with a standard 
wire loop (30 morse guage) having a diameter of 3.26 mm. The 
general culture media used was McConkey (Oxoid No Cm 7) and 





Diagnostic Group). Blood agar (Oxoid No cm 271) was used in the 
case of some fastidious organisms that cannot grow on McConkey 
or CLED. The inoculum on the plate was streaked out for discrete 
colonies with a wire loop using standard method (Onanuga et al., 
2005; Banjo et al., 2005). The culture plates were incubated at a 
temperature of 37oC for a period of 24 h. All the organisms isolated 
were identified by standard technique (Onanuga et al., 2005; 
Cowan and Steel, 1974).  
 
 
Antibiotic susceptibility testing 
 
The antibiotic susceptibility pattern of all the bacterial isolates to 
colistin sulphate 25 µg, nalidixic acid 30 µg, gentamicin 10 µg, co-
trimoxazole 15 µg, nitrofurantoin 200 µg, tetracycline 25 µg, 
amoxycillin 25 µg, cefuroxine 30 µg, Ciproxin 5 µg, Tarivid 5 µg and 
Peflacin 5 µg were determined by the modified Kirby-Bauer 
diffusion technique as earlier described (Onanuga et al., 2005). A 
standard sensitive strain, Escherichia coli Cw3310, was used as the 
control organism. The inoculated plates carrying the antibiotics 
were incubated at 37oC for 24 h after which the diameter of the 
zone of inhibition around each antibiotic disc was measured, and 
isolates were classified as “resistant”, “intermediate sensitive” or 
“sensitive” based on the standard intermediate chart updated 
according to the current NCCLS standard and Fluka zone 
interpretative chart in accordance with WHO requirements 





Of the 700 urine samples collected from the patients, 347 
samples (49.5%), made up of 220 (31.4%) samples from 
females and 127 (18.1%) from males, had infections and 
yielded eight different bacterial isolates (Table 1). The 
highest proportions of bacterial isolates from the samples 
investigated were E. coli (19.7%) and Klebsiella 
aerogenes (15.1%) accounting for 70.3% of the total 
number of isolates recovered from the urine samples. 
The standard strain was sensitive to all the antibiotics 
used. However, all the isolates were “resistant” to 
tetracycline, co-trimoxazole, amoxycillin and cefuroxime 
but were either “intermediate sensitive” or “sensitive” to 
the quinolones, and nitrofurantoin.  
While nitrofurantoin effectively inhibited the growth of 
Providence stuartii and E. coli, the drug intermediately 
inhibited the growth of Proteus mirabilis, Klebsiella 
aerogenes, Alkaligenes faecalis and Acinetobacter 
calcoaceticus (Table 2). Apart from A. calcoaceticus that 
was “sensitive” to ofloxacin and perflacin, the quinolones 
mainly “intermediately” inhibited the growth of the 
bacterial isolates. Nalidixic acid “intermediately” inhibited 
the growth of K. aerogenes while gentamicin moderately 
inhibited the growth of E. coli, aerogenes and P. stuartii. 
Other antimicrobial agents (amoxicillin, tetracycline, 
colistin, and co-trimoxazole) did not effectively inhibit the 





Over the years, antimicrobial agents that are commonly 
used in the treatment of UTIs include trimethoprim-sulpha




Table 1. Distribution of bacteria isolates from urine samples collected from 700 patients in a 
tertiary hospital. 
 




























Table 2. Susceptibility of urine bacteria isolated from 700 patients attending a tertiary hospital to commonly used antimicrobial agents. 
 
% susceptibility to specified antimicrobial agent 


























































































































Proteus mirabilis 47 76.6 70.2 70.2 55.3 38.3 42.6 2.1 4.3 12.8 27.7 2.1 
Escherichia coli 138 93.5 64.5 60.9 68.8 56.5 76.1 23.2 1.4 2.2 11.6 0 
Klebsiella aerogenes 106 79.2 74.5 70.8 71.7 61.3 66.0 33.0 8.5 5.7 18.9 1.9 
Providence stuartii 8 100 87.5 62.5 50.0 50.0 62.5 37.5 0 0 25.0 0 
Alkaligenes faecalis 7 71.4 85.7 71.4 57.1 42.9 42.9 28.6 14.3 0 0 0 
Acinetobacter calcoaceticus 16 62.5 100 62.5 100 0 0 6.3 0 0 0 0 
Pseudomonas aeruginosa 16 0 56.3 56.3 31.3 0 18.8 0 0 0 56.3 0 




methoxazole (co-trimoxazole), ciprofloxacin, ofloxacin, 
nitrofurantoin, gentamicin, ampicillin (Orenstein and 
Wong, 1999), tetracycline, amoxicillin, and nalidixic acid 
(Romac, 1992). Our study has shown a steady and 
generalized increase in bacteria resistance to almost all 
these commonly used antimicrobial agents. For example, 
the sensitivity of E. coli urinary isolates to gentamicin, 
ciprofloxacin, nalidixic acid, tetracycline, and co-
trimoxazole previously reported to be 97.8, 93, 84.6,  
63.2, and 41.6%, respectively (Mansouri and Shareifi, 
2002), has declined considerably. Although amoxicillin 
was frequently earlier suggested as the agent of choice 
for E. coli infections, the bacteria is now commonly 
resistant to the drug as shown in our results. 
Trimethoprim-sulfamethoxazole (co-trimoxazole) has also 
earlier been considered the treatment of choice in E. coli 
infections of the urinary tract but complete resistance of 
E. coli to this drug in recent times, as in our study, has 
previously been reported (Orenstein and Wong, 1999; 
Obaseiki-Ebor, 1988).  
E. coli has the highest occurrence in the bacterial 
isolates from the urine samples we studied and was 
followed by K. aerogenes. This result differs from that 
reported by Akerele et al. (2000), in a five-year (1992-
1996) retrospective study, which indicated that Staph. 
aureus (35.6%) was the most frequently encountered 
single bacteria species in urinary tract infections 
(accounting for 35.65% of the bacteria isolates) and was 
followed by E. coli (accounting for 24.98% of the 
isolates). The high frequency of occurrence of E. coli in 
urinary tract infection in our result may be related to the 
fact that it is most predominant in the gut. An important 
finding in our study is that E. coli and K. aerogenes 
accounted for over 70% of the bacteria isolates 
presenting a challenge to physicians in the management 
of UTIs.  




In the mid 80s, ciprofloxacin proved itself as highly 
effective drug against urinary tract pathogens (Barba et 
al., 1985). Like most other drugs reported in this study, 
the quinolones’ (ciprofloxacin, ofloxacin, and perflacin) 
effectiveness against urinary tract pathogens has 
considerably reduced. Apart from ciprofloxacin exhibiting 
high potency against Streptococcus faecalis, ofloxacin 
exhibiting high potency against Providence species, 
Alkaligenes faecalis and Acinetobacter calcoaceticus, 
and perflacin exhibiting high potency against 
Acinetobacter calcoaceticus, the other isolates are now 
only moderately sensitive to the quinolones we 
investigated. While nalidixic acid has only shown to be 
moderately effective against E. coli and K. aerogenes in 
our investigation, an earlier report has shown only as low 
as 23% of UTI bacteria showing resistant to the drug 
(Barba et al., 1985). Although gentamicin has been a 
very effective drug for the treatment of Gram-negative 
UTI bacteria, including Ps. aeruginosa in the past 
(Romac, 1992), we have observed resistance of Proteus 
mirabilis, Alkaligenes faecalis, Acinetobacter calcoace-
ticus, Ps. aeruginosa and Strep. faecalis against the 
drug.  
When our results are compared with earlier report 
((Romac, 1992), nitrofurantoin has shown continuous 
effectiveness against most urinary tract pathogens. This 
may be explained by the low rate of prescription of the 
drugs in the hospital where this work was carried. Our 
results indicate that the sensitivity of the isolated bacteria 
to cefuroxime, amoxicillin, tetracycline, colistin sulphate 
and co-trimoxazole has declined to a point that these 
antimicrobial agents that were previously relatively highly 
effective against the bacteria are no longer effective as 
single drug in the treatment of any of the bacteria causing 
UTI in the hospital. Unfortunately, amoxicillin, tetracyc-
line, and co-trimoxazole are the commonly used 
antimicrobial agents for this purpose by many individuals, 
particularly those using them for self medication. While 
the high resistance to cefuroxime, amoxicillin, tetracyc-
line, and co-trimoxazole can be explained on the basis of 
indiscriminate use of the antimicrobial agents in the 
community where this study was carried out, colistin 
sulphate may be ineffective because of cross-resistance.  
Previous reports have indicated that the high 
resistance of urinary tract pathogens to antimicrobial 
agents in developing countries (Lester et al., 1990) is 
often due to self-medication, the suboptimal quality of 
antimicrobial drugs, and poor community and patient 
hygiene (Walson et al., 2001). In spite of the continued 
introduction of a variety of antimicrobial agents in multiple 
unrelated drug classes, resistance continues to emerge 
and poses a great challenge for the management of 
UTIs. In this study, many reasons can be adduced for the 
increasing resistance of UTI bacteria to the antimicrobial 
agents. First, there is high prevalence of fake and 
substandard drugs available in Nigeria (Romac, 1992) 





tic doses of drugs. Second, inappropriate use of 
antimicrobial agents in Nigeria is widespread as many 
people can easily buy antibiotics from some pharmacy 
stores and patent medicine stores, with or without 
prescriptions. This widespread and inappropriate use of 
antibiotics is recognized as a significant contributing 
factor to the spread of bacterial resistance and the 
development of resistance to antimicrobial agents 
(Mincey and Parkulo, 2001). Third, there is evidence that 
for most bacteria, increased usage of a particular 
antimicrobial agent correlates with increased levels of 
bacterial resistance to that agent (Granizo et al., 2000). 
Bacterial resistance can results from contaminated food, 
antimicrobial drug exposure, and cross-contamination 
from humans or animals (Lester et al., 1990).  
In conclusion, our results further confirm the numerous 
reports (Amyes, 1987; Chesborough, 1985; Gupto et al., 
1999; Jacoby and Archer, 1991; Ho et al., 2004) in the 
literature on the incidence of growing resistance of 
urinary isolates to available antimicrobial agents. 
Although pharmaceutical companies continue to 
introduce new drugs for the treatment of UTIs, the rapidity 
of emergence of antimicrobial-resistant organisms is not 
being reflected by the same rate of development of new 
antimicrobial agents. It is, therefore, conceivable that 
patients with serious infections will soon no longer be 
treatable with currently available antimicrobials. 
Therefore, the development of antimicrobial policy (which 
is currently non-existence in Nigeria) is a priority. Strict 
management of such antibiotic policies and surveillance 
programmes for resistant organisms, together with 
infection control procedures, need to be implemented and 
continuously audited as suggested by Elliott and Lambert 
(1999). The pharmaceutical industry must respond to 
these clinical challenges by bringing forward a stream of 
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